Long Term Cannabis Use Causes Memory Impairment in Mice
Brain imaging studies showed that the drug impairs function in key brain regions involved in learning and memory.
FDA Warns Against Health Risks of Contaminated Synthetic Cannabis
Reports of severe illnesses and deaths resulting from the use of synthetic cannabinoid products that have been contaminated with brodifacoum, a very long-acting anticoagulant commonly used in rat poison sparked the warning.
CBD Oil: What You Need to Know
Despite CBD oil’s high profile status, there’s still a lot of confusion about what it actually is, and what it’s made from.
PhytaTech CO, Receives Certification for Pesticide Contamination Testing
Pesticide testing is not currently required in Colorado but, scientists at the lab predict that it will in mandated in the coming months.
CBD to be Trialed as Motor Neuron Disease Treatment in Humans
The six-month study will be led by Gold Coast Neurologist, Dr. Arman Sabet who has been involved in many international clinical trials specializing in neuromuscular disorders and stroke.
Cannabinoid Drug to Become Available for Fibromyalgia Patients in Canada
The drug is already being studied in a Phase 3 Health Canada approved clinical trial for advanced cancer pain.
Brain Changes Responsible for Appetite Effects of Cannabis Identified
Deciphering the ways cannabis acts in the body to alter appetite could lead to new treatments for illness-induced anorexia common in cancer, HIV/AIDS, heart disease, and some metabolic disorders.
Coalition Calls for Sickle Cell Cannabis Clinical Trial
To date, the only cure for SCD is a bone marrow transplant, which is costly and out of reach for most patients.
Digipath Labs Hires New Analytical Laboratory Director
Digipath is pleased to announce that Dr. Yunfeng Pan, PhD, has joined Digipath Labs as its Analytical Laboratory Director with oversight of analytical testing procedures.
